10-K: Infleqtion Completes SPAC Merger, Eyes Quantum Advantage

Sentiment:

Annual Report


Infleqtion, Inc. finalized its business combination with Churchill Capital Corp X, becoming a publicly traded quantum technology company focused on sensing, computing, and software.

Capital raiseThe company entered into subscription agreements with PIPE investors on September 8, 2025, to issue and sell $126,547,600 of Domesticated SPAC Common Stock at $10.00 per share.The closing of the PIPE Investment was conditioned on the satisfaction or waiver of conditions in the Merger Agreement.The company will require substantial additional capital to pursue business objectives and respond to opportunities, challenges, or unforeseen circumstances.Future financings may result in dilution to stockholders or issuance of securities with priority.
Worse than expectedThe company reported a net loss of $66,931,068 for the year ended December 31, 2025, which is significantly higher than the $51,910 net loss for the period from January 4, 2024, through December 31, 2024.The accumulated deficit grew to $231.1 million as of December 31, 2025.The company expects the rate of losses to be significantly higher in future periods due to increased R&D, manufacturing investments, and public company expenses.

Summary

  • Infleqtion, Inc. (formerly Churchill Capital Corp X) completed its business combination with ColdQuanta, Inc. on February 13, 2026.
  • The company's common stock and warrants now trade on the NYSE under symbols INFQ and INFQ WS.
  • Infleqtion is developing and commercializing quantum technology products across quantum sensing, quantum computing, and software, built on neutral atom architecture.
  • Key products include Tiqker optical atomic clocks, Sqywire quantum RF sensors, and Exaqt inertial/gravitational sensors, which are already delivering quantum advantage in precision sensing.
  • Its flagship quantum computing system, Sqale, is a room-temperature neutral atom computer with 12 logical qubits demonstrated as of December 31, 2025, targeting 30 logical qubits in 2026 and 100 logical qubits by 2028.
  • Proprietary software, Superstaq, supports quantum-classical workflows, and CML software enhances AI performance on classical GPUs.
  • Revenue is generated through product sales, quantum computing as a service, government-funded R&D contracts, and software licensing.
  • For the year ended December 31, 2025, the company reported a net loss of $66,931,068, compared to a net loss of $51,910 for the period from January 4, 2024, through December 31, 2024.
  • As of December 31, 2025, cash and marketable securities held in the Trust Account totaled $423,689,503.
  • The company had an accumulated deficit of $231.1 million as of December 31, 2025.
  • Sales to the U.S. government and its agencies represented approximately 60% of revenue for fiscal year 2025, with an additional 12% from the UK government.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting the successful public listing and strong technological advancements in quantum computing and sensing, offset by significant and increasing operating losses and the inherent risks of an early-stage, capital-intensive industry.

Positives

  • Successful completion of the business combination and listing on the NYSE.
  • Demonstrated quantum advantage in high-performance quantum clocks and quantum RF sensors.
  • Sqale quantum computing system achieved 99.73% two-qubit CZ gate fidelity, which is believed to be the highest by any commercial neutral atom company.
  • Demonstrated 12 logical qubits as of December 31, 2025, with a roadmap to 30 logical qubits in 2026 and 100 logical qubits by 2028.
  • Diversified revenue model including product sales, quantum computing as a service, government R&D contracts, and software licensing.
  • Strong strategic partnerships with government agencies (U.S. Department of Defense, DARPA, NASA, UK National Quantum Computing Centre, Japan's Quantum Moonshot program) and defense prime contractors (SAIC, L3Harris, Safran, QinetiQ).
  • Proprietary CML software based on quantum physics principles significantly amplifies AI performance on classical GPUs, offering >10x memory savings versus Transformer technology.
  • Vertically integrated, full-stack proprietary quantum platform, enhancing innovation, performance, and manufacturability.
  • Extensive patent portfolio with 125 issued patents and 108 pending applications as of December 31, 2025.
  • Alleviation of substantial doubt about the company's ability to continue as a going concern due to the closing of the Business Combination.

Negatives

  • Significant net loss of $66,931,068 for the year ended December 31, 2025, and an accumulated deficit of $231.1 million.
  • History of operating losses since inception and uncertainty about achieving or sustaining profitability in the future.
  • Business involves immature technology with significant research, development, and manufacturing challenges to produce commercially viable products.
  • No current quantum computers, including Infleqtion's, have reached a broad quantum advantage, and may never reach such advantage.
  • Identified material weaknesses in Legacy Infleqtion's internal control over financial reporting, with remediation efforts potentially extending into 2027.
  • High dependence on key employees with specialized knowledge, making the company vulnerable to turnover.
  • Heavy reliance on sales to government entities (60% U.S. government, 12% UK government in 2025), which are subject to budgetary constraints and termination-for-convenience clauses.
  • Market opportunity estimates and growth forecasts are subject to significant uncertainty and may prove inaccurate.
  • Potential for significant increases in operating losses in future periods due to continued investment in R&D, manufacturing investments, and public company expenses.
  • Risk of supply chain disruptions and reliance on third-party suppliers, including sole-source suppliers.
  • Exposure to risks associated with international operations, including compliance with foreign laws, intellectual property enforcement, and currency fluctuations.
  • Use of generative AI tools may pose risks to proprietary software and systems and subject the company to legal liability.

Risks

  • Business involves technology that is not mature, facing significant barriers in producing products that meet desired technical specifications.
  • History of operating losses and may not achieve or sustain profitability in the future.
  • Failure to adequately fund research and development efforts or use R&D teams effectively could harm business and operating results.
  • If computers fail to achieve a broad quantum advantage, business, financial condition, and future prospects may be harmed.
  • Estimates of market opportunity and forecasts of market growth may prove to be inaccurate.
  • Inability to scale business quickly enough to meet customer and market demand could adversely affect financial condition and results of operations.
  • Business could be harmed if growth is not managed effectively.
  • Even if the market achieves forecasted growth, the business could fail to grow at similar rates.
  • Requires substantial additional capital to pursue business objectives, and additional financing may not be available.
  • Subject to risks associated with current or future partnerships or strategic relationships, and may not maintain current strategic partnerships or realize anticipated benefits.
  • If quantum solutions are not compatible with industry-standard software and hardware, business could be harmed.
  • Quantum technology industry is competitive on a global scale, and success in competing or maintaining confidence in long-term prospects is not guaranteed.
  • Quantum technology industry is in its early stages and volatile; slow development, negative publicity, or lack of commercial engagement could harm business growth.
  • Inability to accurately estimate future supply and demand for products could result in inefficiencies and hinder revenue generation.
  • Future growth and success depends in part on the ability to sell effectively to government entities and large enterprises.
  • Legacy Infleqtion identified material weaknesses in its internal control over financial reporting; ineffective remediation or future weaknesses could impair ability to produce timely and accurate financial statements.
  • Subject to governmental export and import controls and trade and economic sanctions, impairing global competition and subjecting to liability.
  • Contracts with government entities subject the company to risks, including early termination, audits, investigations, sanctions, and penalties.
  • Licensing of intellectual property (e.g., University Licenses from University of Colorado and Wisconsin Alumni Research Foundation) is critical; termination or non-exclusivity could lead to loss of rights to key technologies.
  • Inability to obtain and maintain patent protection, or if protection is not broad enough, competitors could commercialize similar products. Trade secrets could be compromised.
  • Some intellectual property developed through government-funded research may be subject to federal regulations (Bayh-Dole Act), limiting exclusive rights and ability to contract with non-U.S. manufacturers.
  • Market price of common stock may be volatile.
  • Provisions in Certificate of Incorporation requiring exclusive forum in Delaware courts and federal district courts may discourage certain lawsuits.
  • Market values of growth-oriented companies, particularly SPACs, have been affected by adverse economic and market forces.
  • Employees and independent contractors may engage in misconduct or improper activities.
  • Investments may be subject to regulations governing foreign acquisitions of U.S. businesses (CFIUS).
  • Claims for indemnification by directors and officers may reduce available funds.
  • Public Warrants may be redeemed for cash when common stock price equals or exceeds $18.00.
  • No guarantee that Warrants will be in the money at exercisable time, may expire worthless.
  • Uncertain global macroeconomic, political conditions and natural or man-made interruptions could materially adversely affect business prospects, financial condition, results of operations and cash flows.
  • Could suffer future disruptions, outages, defects, and other performance and quality problems with quantum or information systems.
  • Business is dependent on relationships with cloud providers, who also have competitive quantum efforts.
  • International expansion subjects the business to risks associated with foreign operations.
  • Subject to regulations relating to use of radioactive material, compliance may be costly.
  • Subject to environmental and safety regulations and remediation matters.
  • Changes in tax laws could adversely affect business.
  • Operations and business plans could be significantly impacted by changes in federal, state, and local government policies and priorities.
  • Business could be negatively affected by litigation, investigations, and regulatory proceedings.
  • Use of generative AI tools may pose risks to proprietary software and systems and subject to legal liability.

Future Outlook

The company aims to achieve 30 logical qubits in 2026 and 100 logical qubits by 2028, a widely recognized threshold for commercially viable quantum computing. It also targets demonstrating MegaQuOp scale (one million sequential logical operations) in 2028. The near-term commercial strategy focuses on scaling sensing solutions and expanding access to the Sqale computing platform through customer and partner engagements, and broadening software distribution.

Management Comments

  • "Our vision is to harness the power of quantum to expand human potential."
  • "Our approach is grounded in an integrated quantum technology platform, from foundational technology to advanced hardware and propriety software, all built on neutral atoms, natures ideal qubits, which enable an adaptable, scalable and high-fidelity path to quantum advantage across multiple applications."
  • "We believe this result [99.73% CZ gate fidelity] is the highest achieved by any commercial neutral atom company, positioning us at the forefront of the effort to build scalable, fault-tolerant quantum computers."
  • "We believe the quantum sector is entering a pivotal period of accelerated development, analogous to the inflection point seen in the early days of the semiconductor industry."
  • "We are among a select group of companies with both operational quantum products and a credible roadmap to scalable, fault-tolerant quantum computing."
  • "Our strategy is defined by a dual-track approach: advancing toward 100+ logical qubit systems, while simultaneously commercializing quantum sensors that already deliver advantage."

Industry Context

StockSavvy.ai notes that Infleqtion's dual-track strategy, combining near-term commercialization of quantum sensors with a long-term roadmap for fault-tolerant quantum computing, positions it uniquely in an emerging and highly competitive industry. While many competitors focus solely on computing, Infleqtion's operational quantum products and diversified revenue streams provide a more immediate market validation and potentially more stable growth path compared to peers still heavily in pure R&D. The company's neutral atom architecture is gaining momentum, contrasting with other modalities like trapped ion (e.g., IonQ) and superconducting circuits (e.g., IBM, Rigetti), which often require extreme cryogenic cooling.

Comparison to Industry Standards

  • Infleqtion's Sqale system demonstrated 12 logical qubits as of December 2025, with a target of 30 in 2026 and 100 by 2028. This compares to IonQ, which has announced systems with increasing qubit counts (e.g., IonQ Forte with 32 algorithmic qubits), and IBM, which has announced processors with hundreds of physical qubits (e.g., Osprey with 433 physical qubits) and a roadmap towards thousands. The key differentiator for Infleqtion is the neutral atom modality and the focus on *logical* qubits, which are error-corrected, a critical step towards practical quantum computing.
  • The 99.73% two-qubit CZ gate fidelity is stated as the highest achieved by any commercial neutral atom company, indicating a strong technical performance within its specific modality. This is a crucial metric for fault tolerance, where higher fidelity reduces the overhead required for error correction.
  • In quantum sensing, Infleqtion's Tiqker optical atomic clock offers 100 to 1,000 times greater timing performance than conventional atomic clock technologies from incumbent suppliers like Microchip Technology and Safran Electronics & Defense, positioning it as a next-generation alternative for timing-critical missions.
  • The company's CML software, based on quantum physics, achieves >10x memory savings versus Transformer technology on classical GPUs, suggesting a significant performance advantage in AI workloads compared to widely used classical deep learning architectures.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer and DirectorN/A (SPAC CEO)Matthew KinsellaApril 2024 (Infleqtion)Appointment as CEO of combined entity post-merger.
Chief Technology OfficerVice President and General Manager of ComputingPranav GokhaleAugust 2025Promotion within the company.
Chief Financial OfficerGrant Dollens (Interim CFO)Ilan HartNovember 2025Appointment to permanent CFO role.
Chief Revenue OfficerChief Strategy OfficerPaul LipmanOctober 2025Promotion within the company.
Chief Legal OfficerN/AJason HallNovember 2025Appointment to new role.
DirectorErik ThoresenN/ANovember 3, 2025Resignation.
DirectorTimothy DayN/ANovember 3, 2025Resignation.
DirectorN/AEric BjornholtDecember 2025Appointment to the Board.
DirectorN/AKristina JohnsonJune 2024Appointment to the Board.
DirectorN/ADavid SingerApril 2024Appointment to the Board.
Chairman of the BoardN/ACatherine LegoDecember 2023Appointment to the Board.
DirectorN/ADawn MeyerriecksMay 2022Appointment to the Board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board ClassificationBoard is divided into three classes (Class I, II, III) with staggered terms expiring in 2027, 2028, and 2029 respectively. This may delay or prevent changes in control.February 13, 2026 (post-Domestication)Increases stability of board composition but may hinder rapid changes in corporate control.
Director Removal StandardDirectors may only be removed for cause by affirmative vote of at least 66-2/3% of voting stock.February 13, 2026 (post-Domestication)Strengthens director tenure and reduces vulnerability to activist shareholders.
Stockholder Action RequirementAny action by stockholders must be effected at a duly called annual or special meeting, not by written consent.February 13, 2026 (post-Domestication)Limits the ability of stockholders to act quickly without a formal meeting, potentially delaying activist efforts.
Special Meeting Call AuthoritySpecial meetings of stockholders may only be called by a majority of directors then in office, the chairperson of the board, or the CEO/President.February 13, 2026 (post-Domestication)Restricts stockholders' ability to call special meetings, centralizing control with the board and senior management.
Bylaws Amendment ThresholdStockholders can amend certain provisions of the Certificate of Incorporation and Bylaws only upon receiving approval of at least two-thirds of the voting power of outstanding voting securities.February 13, 2026 (post-Domestication)Makes it more difficult for stockholders to unilaterally change key governance provisions.
Exclusive Forum ProvisionCertificate of Incorporation designates the Court of Chancery of Delaware (or other Delaware state/federal courts) as the sole and exclusive forum for certain lawsuits, and federal district courts for Securities Act claims.February 13, 2026 (post-Domestication)Aims to centralize litigation in specific jurisdictions, potentially reducing legal costs and discouraging certain types of lawsuits, but may limit plaintiffs' choice of forum.
Insider Trading PolicyAdopted an Insider Trading Policy prohibiting trading on material nonpublic information, short sales, derivative/hedging transactions, and holding securities in margin accounts. Requires pre-clearance for directors and executive officers.February 13, 2026Enhances compliance with securities laws and reduces risk of insider trading, promoting market integrity.
Incentive Compensation Recoupment PolicyAdopted a policy for recoupment of 'Recoverable Incentive Compensation' from 'Covered Officers' in the event of an 'Accounting Restatement', regardless of fault. Applies to compensation received on or after February 13, 2026.February 13, 2026Aligns executive compensation with financial accuracy and accountability, complying with SEC Rule 10D-1 and NYSE Listing Standards.
Non-Employee Director Compensation PolicyAdopted a policy for annual cash retainers ($45,000 for all, $30,000 for Non-Executive Chair, committee chair/member fees) and equity compensation (Initial Grants of $285,000 Black-Scholes value, Annual Grants of $190,000 Black-Scholes value).February 13, 2026Standardizes and formalizes compensation for non-employee directors, attracting and retaining qualified board members.

Legal Proceedings

  • Management believes there are currently no claims or actions pending against the company that could have a material adverse effect on results of operations, financial condition, or cash flows.

Related Party Transactions

  • Sponsor Founder Shares: Churchill Sponsor X LLC (the Sponsor) acquired 7,187,500 Class B Ordinary Shares for $0.003/share on Feb 15, 2024. Additional shares issued in April and May 2025 via capitalization, resulting in Sponsor holding 10,350,000 Founder Shares. These shares were subject to forfeiture if the over-allotment option was not fully exercised, which it was.
  • Sponsor Private Placement Units: In May 2025, the Sponsor purchased 300,000 Private Placement Units at $10.00/unit for $3,000,000.
  • Administrative Support Agreement: From May 14, 2025, the company reimbursed M. Klein Associates, Inc. (managing member of Sponsor) $30,000/month for office space, utilities, and administrative support. This obligation terminated upon the Business Combination.
  • IPO Promissory Note: On Feb 15, 2024, Sponsor loaned CCX up to $600,000 to cover IPO expenses. This non-interest bearing loan was repaid in full at the IPO closing.
  • Amended and Restated Sponsor Agreement: On Sep 8, 2025, Sponsor and CCX Insiders agreed to vote in favor of the Business Combination and related matters. 1,500,000 Founder Shares held by the Sponsor became subject to vesting based on post-closing stock price performance ($12.00/share trigger within 5 years).
  • Advisory Agreement with The Klein Group, LLC: On Sep 8, 2025, CCX entered into an advisory agreement with The Klein Group, LLC (an affiliate of the Sponsor) for financial advisory, strategy consulting, business development, and investor relations services. Effective upon closing, with a fee of $250,000 per quarter for two years, plus potential additional fees. No payments made in 2025.
  • Maverick Subscription Agreements (PIPE Investment): On Sep 8, 2025, the company entered into subscription agreements with Maverick Capital funds (Maverick PIPE Holders) to purchase 2,500,000 shares of Common Stock for $25,000,000. David Singer, a director, has a financial interest in these entities.
  • Series A Financing (Oct-Dec 2020): Related parties, including entities affiliated with LCP Quantum Partners (Tyler Brous), Global Frontier (Grant Dollens), Maverick (David Singer), and Timothy Day, acquired Infleqtion Series A preferred stock.
  • 2021 Convertible Note Financing (June 2021): Related parties, including entities affiliated with LCP Quantum Partners (Tyler Brous), Global Frontier (Grant Dollens), Maverick (David Singer), and Timothy Day, purchased convertible promissory notes.
  • Series B Financing (June-Oct 2022): Related parties, including entities affiliated with LCP Quantum Partners (Tyler Brous), Global Frontier (Grant Dollens), Maverick (David Singer), BOKA Group Holdings I LP (Erik Thoresen), and Breakthrough Victoria Pty Ltd, acquired Infleqtion Series B/B-1 preferred stock.
  • 2024 SAFE Financing (Apr-May 2024): Related parties, including entities affiliated with LCP Quantum Partners (Tyler Brous), Global Frontier (Grant Dollens), Maverick (David Singer), Lego Holdings, LP (Catherine Lego), The John R. Kinsella Revocable Living Trust (Matthew Kinsella), Kristina M. Johnson Revocable Trust (Kristina Johnson), and Breakthrough Victoria Pty Ltd, purchased Simple Agreements for Future Equity.
  • Series C Financing (Dec 2024-May 2025): Related parties, including entities affiliated with LCP Quantum Partners (Tyler Brous), Global Frontier (Grant Dollens), Maverick (David Singer), Glynn Partners VI, L.P. (Charles Friedland), The John R. Kinsella Revocable Living Trust (Matthew Kinsella), The Day Revocable Trust (Timothy Day), Erik Thoresen, Kristina M. Johnson Revocable Trust (Kristina Johnson), and Breakthrough Victoria Pty Ltd, acquired Infleqtion Series C/C-1 preferred stock.
  • Consulting Agreement with Grant Dollens: Grant Dollens (former director) provided financial and accounting services as Interim CFO from Sep 2024 to Nov 1, 2025, receiving $15,000/month. Paid $48,500 in 2024 and $135,000 in 9 months ended Sep 30, 2025.
  • Consulting Agreement with Timothy Day/Monarch Quantum Inc.: DRS Daylight Solutions, Inc. (where Timothy Day, former director, was an executive) provided engineering services from Nov 1, 2025. Services transitioned to Monarch Quantum Inc. (controlled by Timothy Day) on Dec 16, 2025. Total accounts payable of $1.8 million outstanding as of Dec 31, 2025.
  • Legal Fees to Clif Anderson: Clif Anderson (brother of Chief Science Officer Dana Anderson) received $88,000 in 2024 and $396,000 in 2023 for patent legal services. No payments in 2025.

Stakeholder Impact

  • Shareholders: Potential for dilution from future capital raises and volatility in stock price due to early-stage technology and market forces. Potential for significant returns if quantum advantage is achieved and commercialized successfully.
  • Employees: Opportunities in a growing quantum technology field, but also risks related to high employee turnover in a competitive market for skilled workers.
  • Customers (Government & Enterprise): Access to advanced quantum sensing and computing solutions, potentially offering superior precision and computational power. Risks include delays in product development and the immaturity of the technology.
  • Suppliers: Potential for increased demand as manufacturing scales, but also risks related to supply chain disruptions and reliance on sole-source suppliers.
  • Creditors: Risk associated with the company's history of operating losses and need for substantial additional capital.

Next Steps

  • Achieve 30 logical qubits in 2026.
  • Achieve 100 logical qubits by 2028.
  • Demonstrate MegaQuOp scale (one million sequential logical operations) in 2028.
  • Scale sensor manufacturing.
  • Expand usage of the computing platform through customer and partner engagements.
  • Broaden distribution of Superstaq and CML software offerings.
  • File an amendment to Current Report on Form 8-K, including audited financial statements of Legacy Infleqtion for the year ended December 31, 2025.
  • Remediate identified material weaknesses in internal control over financial reporting, potentially extending into 2027.
  • File a registration statement for resale of certain securities within 30 business days after the Closing Date.

Key Dates

DateDescription
2024-01-04Churchill Capital Corp X (CCX) incorporated in the Cayman Islands as a blank check company.
2024-02-15Sponsor acquired 7,187,500 Founder Shares for approximately $0.003 per share and entered into a loan agreement with CCX for up to $600,000.
2024-04-01Infleqtion issued and sold Simple Agreements for Future Equity (2024 SAFEs) in multiple closings through May 2024.
2024-09-01Infleqtion entered into a consulting agreement with Grant Dollens to become Interim Chief Financial Officer.
2024-12-01Infleqtion issued and sold Series C preferred stock in multiple closings through May 2025.
2025-04-01CCX effected a share capitalization, issuing the Sponsor an additional 1,437,500 Class B Ordinary Shares.
2025-05-01CCX issued an additional 1,725,000 Class B Ordinary Shares in a share capitalization, resulting in the Sponsor holding 10,350,000 Founder Shares.
2025-05-13IPO Registration Statement declared effective; Public Warrant Agreement and Private Warrant Agreement dated.
2025-05-14Securities of the Company first listed; administrative support agreement with Sponsor's managing member commenced ($30,000/month reimbursement).
2025-05-15CCX consummated its Initial Public Offering (IPO) of 41.4 million Public Units at $10.00 per unit, generating $414,000,000 gross proceeds. Simultaneously, Private Placement of 300,000 units to Sponsor for $3,000,000. $414,000,000 placed in Trust Account.
2025-08-01Company entered into Director Agreements with three independent directors, agreeing to pay $75,000 per annum each.
2025-09-01Company engaged Citigroup Global Markets Inc. (Citi) as a placement agent for a proposed PIPE offering.
2025-09-03Company entered into Capital Markets Advisory Agreement with Citi for a $7,000,000 cash fee upon Business Combination consummation.
2025-09-07J.P. Morgan Securities LLC entered into an agreement to serve as Co-Placement Agent for the PIPE offering.
2025-09-08CCX and ColdQuanta, Inc. announced Agreement and Plan of Merger and Reorganization. Company entered into subscription agreements with PIPE investors for $126,547,600 of PIPE shares. Amended and Restated Sponsor Agreement signed, making 1,500,000 Founder Shares subject to vesting.
2025-11-01Consulting agreement with Grant Dollens terminated. DRS Daylight Solutions, Inc. (later Monarch Quantum Inc.) began providing engineering and programming services.
2025-12-05Company formally engaged DRS Daylight Solutions, Inc. for engineering and programming services.
2025-12-16Services agreement transitioned to Monarch Quantum Inc., a company controlled by Timothy Day.
2026-02-12CCX held an extraordinary general meeting of shareholders, approving the Business Combination. CCX deregistered from Cayman Islands and domesticated to Delaware, changing its name to Infleqtion, Inc.
2026-02-13Business Combination consummated. Listing of common stock and warrants moved from Nasdaq to NYSE, changing symbols to INFQ and INFQ WS.
2026-02-17Company filed an amendment to its Current Report on Form 8-K, including audited financial statements of Legacy Infleqtion for 2025.
2026-03-20As of this date, 216,471,927 shares of common stock were issued and outstanding.
2026-03-31Date of this Annual Report on Form 10-K filing.

Recommendation

hold

Infleqtion has successfully completed its SPAC merger and is now publicly traded, a significant milestone. The company demonstrates strong technological capabilities in neutral atom quantum computing and sensing, with a clear roadmap for logical qubit development and existing products delivering quantum advantage. However, it faces substantial financial challenges, including significant and increasing operating losses, an accumulated deficit, and the need for substantial future capital. The quantum technology industry is nascent and highly competitive, with inherent risks related to technology maturity, market adoption, and government funding dependency. A "hold" recommendation reflects the promising long-term potential balanced against the considerable financial and technological risks in the near to medium term. Investors should monitor progress on logical qubit development, commercialization efforts, and financial performance closely.

Keywords

Quantum Technology, Quantum Computing, Quantum Sensing, Neutral Atoms, SPAC Merger, SEC Filing, 10-K, Infleqtion, ColdQuanta, Artificial Intelligence, AI, Superstaq, Sqale, Tiqker, Sqywire, Exaqt, NYSE, IPO, Financial Results, Risk Factors, Corporate Governance, Intellectual Property, Government Contracts, Cybersecurity, Delaware, Warrants, Stock Market, Investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.